Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003
- PMID: 14870793
Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003
Abstract
Background & objectives: Significant progress has been made towards eradication of poliomyelitis in India. Surveillance for acute flaccid paralysis (AFP) has reached high standards. Among the 3 types of polioviruses, type 2 had been eliminated in India and eradicated globally as of October 1999. However, we isolated wild poliovirus type 2 from a small number of polio cases in northern India in 2000 and again during December 2002 to February 2003. Using molecular tools the origin, of the wild type 2 poliovirus was investigated.
Methods: Polioviruses isolated from stool samples collected from patients with AFP were differentiated as wild virus or Sabin vaccine-like by ELISA and probe hybridization assays. Complete VP1 gene nucleotide sequences of the wild type 2 poliovirus isolates were determined by reverse transcriptase polymerase chain reaction (RT-PCR), followed by cycle sequencing. VP1 nucleotide sequences were compared with those of wild type 2 polioviruses that were indigenous in India in the past as well as prototype/laboratory strains and the GenBank database.
Results: Wild poliovirus type 2 was detected in stool samples from 6 patients with AFP in western Uttar Pradesh and 1 in Gujarat. In addition, the virus was isolated from one healthy contact child and from environmental sewage sample in Moradabad where three of these patients were reported. These isolates were identified as genetically closely related to laboratory reference strain MEF-1. Molecular characterization of the isolates confirmed that there was no evidence of extensive person-to-person transmission of the virus in the community.
Interpretation & conclusion: Laboratory reference strain (MEF-1) of poliovirus type 2 caused paralytic poliomyelitis in 10 patients in September 2000 and November 2002 to February 2003. The origin of the virus was some laboratory as yet not identified. This episode highlights the urgent need for stringent containment of wild poliovirus containing materials in the laboratories across the country in order to prevent recurrence of such incidents.
Similar articles
-
Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.J Med Virol. 2008 Aug;80(8):1477-88. doi: 10.1002/jmv.21230. J Med Virol. 2008. PMID: 18551602
-
Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.J Clin Virol. 2007 Aug;39(4):304-7. doi: 10.1016/j.jcv.2007.04.017. Epub 2007 Jun 21. J Clin Virol. 2007. PMID: 17590391
-
Annual report of the Australian National Poliovirus Reference Laboratory, 2002.Commun Dis Intell Q Rep. 2003;27(3):352-6. Commun Dis Intell Q Rep. 2003. PMID: 14510060
-
Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013.J Infect Dis. 2014 Nov 1;210 Suppl 1:S304-14. doi: 10.1093/infdis/jiu294. J Infect Dis. 2014. PMID: 25316849 Review.
-
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.J Infect Dis. 1997 Feb;175 Suppl 1:S176-82. doi: 10.1093/infdis/175.supplement_1.s176. J Infect Dis. 1997. PMID: 9203713 Review.
Cited by
-
Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.J Gen Virol. 2023 Jun;104(6):001867. doi: 10.1099/jgv.0.001867. J Gen Virol. 2023. PMID: 37390009 Free PMC article.
-
Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.bioRxiv [Preprint]. 2023 Feb 2:2023.01.30.526315. doi: 10.1101/2023.01.30.526315. bioRxiv. 2023. Update in: J Gen Virol. 2023 Jun;104(6). doi: 10.1099/jgv.0.001867. PMID: 36778240 Free PMC article. Updated. Preprint.
-
Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsids.J Gen Virol. 2022 Aug;103(8):001771. doi: 10.1099/jgv.0.001771. J Gen Virol. 2022. PMID: 35997623 Free PMC article.
-
Poliovirus containment risks and their management.Future Virol. 2018 Aug 10;13(9):617-628. doi: 10.2217/fvl-2018-0079. Future Virol. 2018. PMID: 33598044 Free PMC article.
-
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018.Vaccines (Basel). 2020 Jun 22;8(2):331. doi: 10.3390/vaccines8020331. Vaccines (Basel). 2020. PMID: 32580378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous